8 drug(s) with this reaction
7,254 total reports
Renal Failure has been reported as an adverse reaction across 8 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 7,254 adverse event reports mention renal failure in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with renal failure, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have renal failure listed in their FDA adverse event reports, sorted by report count:
In addition to renal failure, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
8 drug(s) manufactured by Abbvie Inc have renal failure listed in their FDA adverse event reports: LEVOTHYROXINE SODIUM, FENOFIBRATE, RITONAVIR, LOPINAVIR AND RITONAVIR, VENETOCLAX, and others.
There are a combined 7,254 reports of renal failure across 8 Abbvie Inc drug(s) in the FDA adverse event database.